Monogram Orthopaedics (NASDAQ:MGRM) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Monogram Orthopaedics (NASDAQ:MGRM) posted its quarterly earnings results on Wednesday. The company reported ($0.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.03, Zacks reports.

Monogram Orthopaedics Trading Up 2.2 %

Monogram Orthopaedics stock traded up $0.05 during midday trading on Wednesday, hitting $2.32. 42,956 shares of the stock were exchanged, compared to its average volume of 142,773. The stock’s 50-day simple moving average is $2.54 and its 200 day simple moving average is $2.50. The stock has a market capitalization of $79.60 million, a price-to-earnings ratio of -4.94 and a beta of 1.66. Monogram Orthopaedics has a fifty-two week low of $1.53 and a fifty-two week high of $4.90.

Analysts Set New Price Targets

Several brokerages have recently weighed in on MGRM. Roth Mkm assumed coverage on Monogram Orthopaedics in a report on Monday, December 9th. They set a “buy” rating and a $4.00 target price on the stock. Roth Capital raised Monogram Orthopaedics to a “strong-buy” rating in a research note on Monday, December 9th.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.